Cigna launches Lead to One plan and Cigna Group stock costs EUR 241.65

Published on 10/06/2026 at 13:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cigna targets 10.00-14.00 percent adjusted EPS growth through 2030. Cigna Group stock costs EUR 241.65 on October 6, 2026 versus EUR 242.75.

Redaktionelles Foto des NYSE-Handelssaals mit Händlern und Bildschirmen voller Gesundheitssektor-Charts — Cigna Group NYSE-Börsensaal Editorial mit Händlern und Gesundheitssektor-Charts, ISIN US1255231003, auf großen S&P-500-Bildschirmen, Illustration mit AI erstellt.

Cigna launched its Lead to One vision at its September 30, 2026 Investor Day, while Cigna Group stock was trading at EUR 241.65 at Lang & Schwarz on October 6, 2026. The company also announced a USD 3.00 billion modernization and productivity initiative, giving the strategy a measurable operating target.

Guidance stays firmly defined

According to PR Newswire on September 30, 2026, Cigna reaffirmed 2026 adjusted revenue guidance of USD 280.0 billion and adjusted earnings per share of at least USD 30.45. The company also maintained guidance for Evernorth Health Services adjusted income from operations of at least USD 6.90 billion and Cigna Healthcare adjusted income from operations of at least USD 4.55 billion.

The guidance sets a clear near-term baseline rather than a fresh increase. Cigna targets 10.00-14.00 percent annual adjusted earnings per share growth through 2030, alongside approximately USD 50.0 billion in cumulative operating cash flow over 2026 through 2030.

Complex care is the growth pillar

The strategy centers on combining Cigna Healthcare with Evernorth Health Services, particularly specialty care, pharmacy benefit services and data-supported care management. Reuters reported on September 30, 2026, that the company expects adjusted earnings per share to grow 10.00-14.00 percent annually and aims for USD 3.00 billion in cost savings by 2030.

For the second quarter of 2026, revenue rose 7.00 percent to USD 71.7 billion and adjusted earnings per share reached USD 7.78, according to Quartr. That comparison gives the long-term targets an operating reference: the company is entering the strategy period with reported quarterly revenue growth, while pharmacy benefit services remain exposed to changing rebate conditions.

Stock quote and investor frame

Cigna Group stock was trading at EUR 241.65 at Lang & Schwarz on October 6, 2026 at 1:31 p.m. CEST, down EUR 1.10 or minus 0.45 percent versus the Lang & Schwarz prior close of EUR 242.75 on October 5, 2026. The primary listing is on the NYSE, where the finance quote showed a market capitalization of USD 71.7 billion and a 52-week range of USD 239.51 to USD 312.18 as of October 5, 2026.

The further course of trading is shown by the continuously updated real-time quote of Cigna Group stock.